IL129368A0 - Immunogenic TLP composition - Google Patents

Immunogenic TLP composition

Info

Publication number
IL129368A0
IL129368A0 IL12936897A IL12936897A IL129368A0 IL 129368 A0 IL129368 A0 IL 129368A0 IL 12936897 A IL12936897 A IL 12936897A IL 12936897 A IL12936897 A IL 12936897A IL 129368 A0 IL129368 A0 IL 129368A0
Authority
IL
Israel
Prior art keywords
seq
immunogenic
tlp
composition
tlp composition
Prior art date
Application number
IL12936897A
Other languages
English (en)
Original Assignee
Inst Farmacoterapico Italiano
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Farmacoterapico Italiano filed Critical Inst Farmacoterapico Italiano
Publication of IL129368A0 publication Critical patent/IL129368A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00Cellular immunotherapy
    • A61K40/10Cellular immunotherapy characterised by the cell type used
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00Cellular immunotherapy
    • A61K40/40Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41Vertebrate antigens
    • A61K40/42Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/80Vaccine for a specifically defined cancer
    • A61K2039/86Lung
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/80Vaccine for a specifically defined cancer
    • A61K2039/892Reproductive system [uterus, ovaries, cervix, testes]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/46Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
    • A61K2239/55Lung

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
IL12936897A 1996-10-09 1997-10-09 Immunogenic TLP composition IL129368A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96RM000687A IT1294967B1 (it) 1996-10-09 1996-10-09 Composizione immunogenica da tlp
PCT/IT1997/000240 WO1998015282A1 (en) 1996-10-09 1997-10-09 Immunogenic tlp composition

Publications (1)

Publication Number Publication Date
IL129368A0 true IL129368A0 (en) 2000-02-17

Family

ID=11404462

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12936897A IL129368A0 (en) 1996-10-09 1997-10-09 Immunogenic TLP composition

Country Status (17)

Country Link
US (2) US20020031531A1 (it)
EP (1) EP0938329B1 (it)
JP (1) JP2001508764A (it)
KR (1) KR20000048995A (it)
CN (1) CN1239431A (it)
AT (1) ATE218064T1 (it)
AU (1) AU725218B2 (it)
CA (1) CA2267905A1 (it)
DE (2) DE938329T1 (it)
DK (1) DK0938329T3 (it)
ES (1) ES2138574T3 (it)
IL (1) IL129368A0 (it)
IT (1) IT1294967B1 (it)
NO (1) NO991653L (it)
PT (1) PT938329E (it)
RU (1) RU2192274C2 (it)
WO (1) WO1998015282A1 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1317853B1 (it) * 2000-02-25 2003-07-15 Unihart Corp Peptidi tlp e sequenze di dna che li codificano.
RU2192884C2 (ru) * 2000-11-09 2002-11-20 Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН Вакцина для стимуляции противоопухолевого иммунитета
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
CA2593086A1 (en) 2004-12-30 2006-07-06 Vito Michele Fazio Anti-tumoral immunogenic peptides and vaccine thereof
AU2008343758A1 (en) * 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars
ITRM20100256A1 (it) * 2010-05-19 2011-11-20 Farmafin Spa Un nuovo biomarcatore per la diagnosi precoce e l'immunoterapia del cancro
EP3167898A1 (en) 2015-11-11 2017-05-17 IEO - Istituto Europeo di Oncologia Srl Method for obtaining tumor peptides and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1206250B (it) * 1987-02-18 1989-04-14 Ist Farmacoterapico It Spa Stiche umane e relativi prodotti metodo per l'estrazione di antigeni di membrana aventi proprieta' immunogene a partire da cellule neopla-
IT1262954B (it) * 1992-07-03 1996-07-23 Ist Farmacoterapico It Spa Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.

Also Published As

Publication number Publication date
EP0938329A1 (en) 1999-09-01
DE938329T1 (de) 2000-04-06
ITRM960687A1 (it) 1998-04-09
CN1239431A (zh) 1999-12-22
AU725218B2 (en) 2000-10-05
RU2192274C2 (ru) 2002-11-10
US20040022870A1 (en) 2004-02-05
NO991653L (no) 1999-06-08
ES2138574T1 (es) 2000-01-16
KR20000048995A (ko) 2000-07-25
ES2138574T3 (es) 2002-11-01
EP0938329B1 (en) 2002-05-29
AU4637697A (en) 1998-05-05
CA2267905A1 (en) 1998-04-16
PT938329E (pt) 2002-10-31
US20020031531A1 (en) 2002-03-14
JP2001508764A (ja) 2001-07-03
DK0938329T3 (da) 2002-09-09
WO1998015282A1 (en) 1998-04-16
IT1294967B1 (it) 1999-04-23
ATE218064T1 (de) 2002-06-15
NO991653D0 (no) 1999-04-08
DE69712907D1 (de) 2002-07-04
DE69712907T2 (de) 2002-12-12

Similar Documents

Publication Publication Date Title
EP2258383A3 (en) Antigenic peptides derived from telomerase
WO1998007745A3 (en) Compositions and methods for treating infections using analogues of indolicidin
NZ516381A (en) Lung tumor proteins in the therapy and diagnosis of lung cancer
ATE280826T1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
WO1998033509A3 (en) Useful properties of human lactoferrin and variants thereof
AUPN568095A0 (en) Anti-Galalpha(1,3)Gal antibody binding peptides
WO1998040401A3 (en) Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
NZ335485A (en) Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
IL125590A (en) Peptide immunogens, process for their preparation and use thereof as vaccines against allergies
ZA9810679B (en) Antimicrobial peptides.
GR3035440T3 (en) Therapeutic uses of bpi protein products for human meningococcemia
NZ279963A (en) Human tissue inhibitor of metalloproteinase-4 (timp-4) and dna (rna) encoding polypeptide which may be derived from atcc 75946
CA2234263A1 (fr) Composition pharmaceutique contre les tumeurs et infections a papillomavirus
MX9602570A (es) Metodos y materiales anti-fungosos.
WO1996028470A3 (en) Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
IL135687A0 (en) A novel human checkpoint kinase, hcds1, compositions and methods
IL111198A0 (en) Muramyl peptide compounds in the treatment or prophylaxis of cancer
IL129368A0 (en) Immunogenic TLP composition
BG103872A (en) Glycoconjugates of 20(s)-camptotecin
NZ518772A (en) Polypeptide fragments comprising c-terminal portion of helicobacter catalase
AU3711597A (en) A novel galanin receptor
UA83989C2 (ru) Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение
EP0782630A4 (en) GENES OF RENAL POLYKYSTOSIS
EP1174439A3 (en) Compositions and methods for treating infections using analogues of indolicidin